VALENTINA GOULARTE: Open Payments
NPI 1083208466 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,029 in 6 payments from 4 companies in 2025. Trend: 2023 $125 · 2024 $544 · 2025 $3,029
Speaker / faculty: $2,550Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $2,675 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Astellas Pharma US Inc | 1 | $118 |
Products named: RYBREVANT, OPDIVO, Vyloy.
Industry payments across MD — which companies pay providers there.
